XML 30 R12.htm IDEA: XBRL DOCUMENT
v3.24.3

Employee Benefit Plans | 12 Months Ended
--- | ---
Sep. 29, 2024
Employee Benefit and Share-Based Payment Arrangement, Noncash Expense [Abstract] |
Employee Benefit Plans | Employee Benefit Plans Equity Compensation Plans. On March 5, 2024, our stockholders approved the Amended and Restated Qualcomm Incorporated 2023 Long-Term Incentive Plan (the 2023 Plan), including an increase in the share reserve by 15 million shares. The 2023 Plan provides for the grant of RSUs and other stock-based awards. The RSUs generally include dividend-equivalent rights and vest over three years from the date of grant. The Board of Directors may amend or terminate the 2023 Plan at any time. Certain amendments, including an increase in the share reserve, require stockholder approval. At September 29, 2024, approximately 75 million shares were available for future grant under the 2023 Plan. The following is a summary of employee RSU transactions that contain only service requirements to vest:
| Number of Shares (in millions) |  | Weighted-Average Grant Date Fair Value |  |
RSUs outstanding at September 24, 2023 | 35 |  |  | $ | 122.86 |  |  |
RSUs granted | 21 |  |  | 134.31 |  |  |
RSUs canceled/forfeited | (3) |  |  | 124.84 |  |  |
RSUs vested | (25) |  |  | 124.45 |  |  |
RSUs outstanding at September 29, 2024 | 28 |  |  | 129.61 |  |  |
The weighted-average estimated grant date fair values of employee RSUs that contain only service requirements to vest granted during fiscal 2023 and 2022 were $116.80 and $136.09 per share, respectively. Upon vesting, we issue new shares of common stock. For the majority of RSUs, shares are issued on the vesting dates net of the amount of shares needed to satisfy statutory tax withholding requirements to be paid by us on behalf of the employees. As a result, the actual number of shares issued will be fewer than the number of RSUs outstanding. The annual pre-vest forfeiture rate for RSUs was estimated to be approximately 6%, 7% and 6% in fiscal 2024, 2023 and 2022, respectively. At September 29, 2024, total unrecognized compensation expense related to such non-vested RSUs granted prior to that date was $2.9 billion, which is expected to be recognized over a weighted-average period of 1.7 years. The total vest-date fair value of such RSUs that vested during fiscal 2024, 2023 and 2022 was $4.0 billion, $2.1 billion and $2.9 billion, respectively. The total shares withheld to satisfy statutory tax withholding requirements related to all share-based awards were 6 million, 4 million and 5 million in fiscal 2024, 2023 and 2022, respectively and were based on the value of the awards on their vesting dates as determined by our closing stock price. The total tax benefits realized, including the excess tax benefits, related to share-based awards during fiscal 2024, 2023 and 2022 were $840 million, $435 million and $627 million, respectively. Employee Stock Purchase Plan. We have an employee stock purchase plan that allows eligible employees to purchase shares of common stock at 85% of the value of our common stock on specific dates through periodic payroll deductions. The shares reserved for future issuance under the employee stock purchase plan were 15 million at September 29, 2024. We recorded cash received from the exercise of purchase rights of $379 million, $395 million and $355 million during fiscal 2024, 2023 and 2022, respectively. Share-based Compensation Expense. Total share-based compensation expense, related to all of our share-based awards, was comprised as follows (in millions):
|  |  |  |  | 2024 |  | 2023 |  | 2022
Cost of revenues |  |  |  |  |  |  |  |  | $ | 89 |  |  | $ | 76 |  |  | $ | 61 |
Research and development |  |  |  |  |  |  |  |  | 2,024 |  |  | 1,911 |  |  | 1,537 |
Selling, general and administrative |  |  |  |  |  |  |  |  | 535 |  |  | 497 |  |  | 463 |
Share-based compensation expense before income taxes |  |  |  |  |  |  |  |  | 2,648 |  |  | 2,484 |  |  | 2,061 |
Related income tax benefit |  |  |  |  |  |  |  |  | (662) |  |  | (463) |  |  | (489) |
|  |  |  |  |  |  |  |  | $ | 1,986 |  |  | $ | 2,021 |  |  | $ | 1,572 |

X
- Definition The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 710 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/710/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 712 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/712/tableOfContent Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 715 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/715/tableOfContent Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent + Details
Name: | us-gaap_CompensationAndEmployeeBenefitPlansTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EmployeeBenefitsAndShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration